[moc::""]
>[!title]
> _Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site_
> Galloway. Fox Chase. 2015. Review.

# Takeaways
- RT
	- mucosal targets
		- always include OPx bilaterally 
		- can omit NPx (especially in HPV+/EBV-)
			- try to include retropharyngeal nodes, regardless
	- Dose
		- 66-70 gross
		- 60-66 high-risk
		- 45-54 elective
- Chemo
	- maybe if there's ECE, but otherwise unnecessary.
		- DM rare, never locally advanced so chemo isn't adding anything



>[!summary]
>| stage | Tx recs                                                                                                     |
>| ----- | ----------------------------------------------------------------------------------------------------------- |
>| N1    | LND or RT                                                                                                   |
>| N2a   | LND or RT<br> -if p16- or >10y smoking ([[RTOG 0129 + RTOG 0522\|RTOG 0129]]): LND+PORT |
>| N2b   | LND+PORT vs CCRT                                                                                            |
>| N2c   | CCRT                                                                                                        |
>| N3    | CCRT (vs LND+PORT)                                                                                          |
>| ECE   | CCRT                                                                                                        | 
>^summary

# PDF
![[08_Galloway.pdf]]